Used in pharmaceutical synthesis as a chiral building block for protease inhibitors, particularly in the development of antiviral drugs. Its structure supports selective binding and metabolic stability, making it valuable in optimizing drug candidates targeting viral replication. Commonly employed in asymmetric synthesis to introduce stereochemical control in active pharmaceutical ingredients (APIs).